-
1
-
-
34249671350
-
Oral contraception in diabetic women. Diabetes control, serum and high density lipoprotein lipids during low-dose progestogen, combined oestrogen/progestogen and non-hormonal contraception [Hormonell och ickehormonell contraception i relation till diabeteskontroll och lipidmetabolism]
-
Radberg T, Gustafson A, Karlsson K, Skryten A. Oral contraception in diabetic women. Diabetes control, serum and high density lipoprotein lipids during low-dose progestogen, combined oestrogen/progestogen and non-hormonal contraception [Hormonell och ickehormonell contraception i relation till diabeteskontroll och lipidmetabolism]. Acta Societatis Medicorum Suecanae 1979;88:212.
-
(1979)
Acta Societatis Medicorum Suecanae
, vol.88
, pp. 212
-
-
Radberg, T.1
Gustafson, A.2
Karlsson, K.3
Skryten, A.4
-
2
-
-
0020037906
-
-
* Radberg T, Gustafson A, Skryten A, Karlsson K. Oral contraception in diabetic women. A cross-over study on serum and high density lipoprotein (HDL) lipids and diabetes control during progestogen and combined estrogen/progestogen contraception. Hormone and metabolic research 1982;14:61-5.
-
* Radberg T, Gustafson A, Skryten A, Karlsson K. Oral contraception in diabetic women. A cross-over study on serum and high density lipoprotein (HDL) lipids and diabetes control during progestogen and combined estrogen/progestogen contraception. Hormone and metabolic research 1982;14:61-5.
-
-
-
-
3
-
-
15944422878
-
Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: A randomized trial
-
Rogovskaya S, Rivera R, Grimes DA, Chen PL, Pierre-Louis B, Prilepskaya V, et al. Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trial. Obstetrics and gynaecology 2005;105:811-5.
-
(2005)
Obstetrics and gynaecology
, vol.105
, pp. 811-815
-
-
Rogovskaya, S.1
Rivera, R.2
Grimes, D.A.3
Chen, P.L.4
Pierre-Louis, B.5
Prilepskaya, V.6
-
4
-
-
0023033219
-
Oral contraceptives in diabetic women: Metabolic effects of four compounds with different estrogen/progestogen profiles
-
Skouby SO, Molsted-Pedersen L, Kuhl C, Bennet P. Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progestogen profiles. Fertility and sterility 1986;46:858-64.
-
(1986)
Fertility and sterility
, vol.46
, pp. 858-864
-
-
Skouby, S.O.1
Molsted-Pedersen, L.2
Kuhl, C.3
Bennet, P.4
-
5
-
-
0017265617
-
The effect of various contraceptive hormonal therapies in women with normal and diabetic oral glucose tolerance test
-
Aznar R, Lara R, Zarco D, Gonzalez L. The effect of various contraceptive hormonal therapies in women with normal and diabetic oral glucose tolerance test. Contraception 1976;13:299-311.
-
(1976)
Contraception
, vol.13
, pp. 299-311
-
-
Aznar, R.1
Lara, R.2
Zarco, D.3
Gonzalez, L.4
-
6
-
-
0034110211
-
Contraception in diabetic women: Comparative metabolic study of Norplant, depot Medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A
-
Diab KM, Zaki MM. Contraception in diabetic women: comparative metabolic study of Norplant, depot Medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A. The journal of obstetrics and gynaecology research 2000;26:17-26.
-
(2000)
The journal of obstetrics and gynaecology research
, vol.26
, pp. 17-26
-
-
Diab, K.M.1
Zaki, M.M.2
-
7
-
-
0032950721
-
Mortality and hormone-related exposures in women with diabetes
-
Klein BE, Klein R, Moss SE. Mortality and hormone-related exposures in women with diabetes. Diabetes care 1999;22:248-52.
-
(1999)
Diabetes care
, vol.22
, pp. 248-252
-
-
Klein, B.E.1
Klein, R.2
Moss, S.E.3
-
8
-
-
0027937293
-
Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus
-
Petersen KR, Skouby SO, Sidelmanm J, Molsted-Pedersen L, Jespersen J. Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus. American journal of obstetrics and gynecology 1994;171:400-5.
-
(1994)
American journal of obstetrics and gynecology
, vol.171
, pp. 400-405
-
-
Petersen, K.R.1
Skouby, S.O.2
Sidelmanm, J.3
Molsted-Pedersen, L.4
Jespersen, J.5
-
9
-
-
0029015188
-
Hormonal contraception in women with IDDM. Influence on glycometabolic control and lipoprotein metabolism
-
Petersen KR, Skouby SO, Vedel P, Haaber A. Hormonal contraception in women with IDDM. Influence on glycometabolic control and lipoprotein metabolism. Diabetes care 1995;18:800-6.
-
(1995)
Diabetes care
, vol.18
, pp. 800-806
-
-
Petersen, K.R.1
Skouby, S.O.2
Vedel, P.3
Haaber, A.4
-
10
-
-
0029927912
-
Diabetes regulation and oral contraceptives. Lipoprotein metabolism in women with insulin dependent diabetes mellitus using oral contraceptives [Diabetesregulering og p-pillen]
-
Petersen KR, Skouby SO, Jespen PV, Haaber AB. Diabetes regulation and oral contraceptives. Lipoprotein metabolism in women with insulin dependent diabetes mellitus using oral contraceptives [Diabetesregulering og p-pillen]. Ugeskrift for laeger 1996;158:2388-92.
-
(1996)
Ugeskrift for laeger
, vol.158
, pp. 2388-2392
-
-
Petersen, K.R.1
Skouby, S.O.2
Jespen, P.V.3
Haaber, A.B.4
-
11
-
-
0014204475
-
Impairment of diabetic control by norethynodrel with mestranol
-
Reder JA, Tulgan H. Impairment of diabetic control by norethynodrel with mestranol. New York state journal of medicine 1967;67:1073-4.
-
(1967)
New York state journal of medicine
, vol.67
, pp. 1073-1074
-
-
Reder, J.A.1
Tulgan, H.2
-
14
-
-
34249693748
-
Analysing and presenting results
-
Deeks JJ, Higgins JPT, Altman DG, editors, Chichester, UK: John Wiley & Sons, LTD
-
Deeks JJ, Higgins JPT, Altman DG, editors. Analysing and presenting results. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 (updated May 2005);section 8. In The Cochrane Library, Issue 3,2005. Chichester, UK: John Wiley & Sons, LTD, 2005.
-
(2005)
Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 (updated May 2005);section 8. In The Cochrane Library, Issue 3,2005
-
-
-
17
-
-
0000529264
-
Intergenerational class mobility and the convergence thesis: England, France, and Sweden
-
Erikson R, Goldthorpe JH, Portocarero L. Intergenerational class mobility and the convergence thesis: England, France, and Sweden. The British journal of sociology 1983;34:303-343.
-
(1983)
The British journal of sociology
, vol.34
, pp. 303-343
-
-
Erikson, R.1
Goldthorpe, J.H.2
Portocarero, L.3
-
18
-
-
0024333622
-
Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study
-
Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult N, et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989;32:300-4.
-
(1989)
Diabetologia
, vol.32
, pp. 300-304
-
-
Fontbonne, A.1
Eschwege, E.2
Cambien, F.3
Richard, J.L.4
Ducimetiere, P.5
Thibult, N.6
-
19
-
-
0025905855
-
Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: The Paris Prospective Study, 15-year follow-up
-
Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, et al. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 1991;34:356-61.
-
(1991)
Diabetologia
, vol.34
, pp. 356-361
-
-
Fontbonne, A.1
Charles, M.A.2
Thibult, N.3
Richard, J.L.4
Claude, J.R.5
Warnet, J.M.6
-
20
-
-
0028316237
-
Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus
-
Garg SK, Chase HP, Marshall G, Hoops SL, Holmes DL, Jackson WE. Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus. The journal of the American Medical Association 1994;271:1099-102.
-
(1994)
The journal of the American Medical Association
, vol.271
, pp. 1099-1102
-
-
Garg, S.K.1
Chase, H.P.2
Marshall, G.3
Hoops, S.L.4
Holmes, D.L.5
Jackson, W.E.6
-
21
-
-
34249752295
-
-
Girling J, Dornhorst A. Pregnancy and diabetes mellitus. In: PickupJC, WilliamsG editor(s). Textbook of diabetes 2; section 65. Oxford, UK: Blackwell Science Ltd, 2003.
-
Girling J, Dornhorst A. Pregnancy and diabetes mellitus. In: PickupJC, WilliamsG editor(s). Textbook of diabetes 2; section 65. Oxford, UK: Blackwell Science Ltd, 2003.
-
-
-
-
22
-
-
0025201663
-
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism
-
Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. The New England journal of medicine 1990;323:1375-81.
-
(1990)
The New England journal of medicine
, vol.323
, pp. 1375-1381
-
-
Godsland, I.F.1
Crook, D.2
Simpson, R.3
Proudler, T.4
Felton, C.5
Lees, B.6
-
23
-
-
0026579457
-
Insulin resistance, secretion, and metabolism in users of oral contraceptives
-
Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V. Insulin resistance, secretion, and metabolism in users of oral contraceptives. The journal of clinical endocrinology and metabolism 1992;74:64-70.
-
(1992)
The journal of clinical endocrinology and metabolism
, vol.74
, pp. 64-70
-
-
Godsland, I.F.1
Walton, C.2
Felton, C.3
Proudler, A.4
Patel, A.5
Wynn, V.6
-
24
-
-
0030460278
-
The influence of female sex steroids on glucose metabolism and insulin action
-
Godsland IF. The influence of female sex steroids on glucose metabolism and insulin action. Journal of internal medicine 1996;738(supplement) :1-60.
-
(1996)
Journal of internal medicine
, vol.738
, Issue.SUPPL.EMENT
, pp. 1-60
-
-
Godsland, I.F.1
-
25
-
-
0033756472
-
Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms
-
Godsland IF, Winkler U, Lidegaard O, Crook D. Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms. Drugs 2000;60:721-869.
-
(2000)
Drugs
, vol.60
, pp. 721-869
-
-
Godsland, I.F.1
Winkler, U.2
Lidegaard, O.3
Crook, D.4
-
26
-
-
17644412369
-
Surrogate end points in clinical research: Hazardous to your health
-
Grimes DA, Schulz KF. Surrogate end points in clinical research: hazardous to your health. Obstet Gynecol 2005;105:1114-8.
-
(2005)
Obstet Gynecol
, vol.105
, pp. 1114-1118
-
-
Grimes, D.A.1
Schulz, K.F.2
-
27
-
-
34249679306
-
Obstetrie en gynaecologie. De voortplanting van de mens; section 12
-
Heinenman MJ, Bleker OP, Evers JLH, Heintz APM, editors, the Netherlands: Elsevier/ Bunge
-
Heinenman MJ, Bleker OP, Evers JLH, Heintz APM, editors. Obstetrie en gynaecologie. De voortplanting van de mens; section 12. third. Maarssen, the Netherlands: Elsevier/ Bunge, 1999.
-
(1999)
third. Maarssen
-
-
-
28
-
-
0028606482
-
Contraception in patients with type I diabetes: A survey of 808 women of reproductive age
-
Kimmerle R, Schmitt G, Berger M. Contraception in patients with type I diabetes: a survey of 808 women of reproductive age. Geburtshilfe und Frauenheilkunde 1994;54:691-6.
-
(1994)
Geburtshilfe und Frauenheilkunde
, vol.54
, pp. 691-696
-
-
Kimmerle, R.1
Schmitt, G.2
Berger, M.3
-
29
-
-
0026787358
-
Contraception in women with IDDM. An epidemicological study
-
Kjær K, Hagen C, Sandø SH, Eshøj O. Contraception in women with IDDM. An epidemicological study. Diabetes Care 1992;15:1585-90.
-
(1992)
Diabetes Care
, vol.15
, pp. 1585-1590
-
-
Kjær, K.1
Hagen, C.2
Sandø, S.H.3
Eshøj, O.4
-
30
-
-
0033364365
-
Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy
-
Klein BE, Klein R, Moss SE. Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes care 1999;22:1984-7.
-
(1999)
Diabetes care
, vol.22
, pp. 1984-1987
-
-
Klein, B.E.1
Klein, R.2
Moss, S.E.3
-
31
-
-
0038439242
-
Pharmaceutical industry sponsorship and research outcome and quality: Systematic review
-
Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70.
-
(2003)
BMJ
, vol.326
, pp. 1167-1170
-
-
Lexchin, J.1
Bero, L.A.2
Djulbegovic, B.3
Clark, O.4
-
32
-
-
0035955925
-
Prevention of Renal and Vascular End Stage Disease Study Group. Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria
-
Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT, Prevention of Renal and Vascular End Stage Disease Study Group. Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. Archives of internal medicine 2001;161:2000-5.
-
(2001)
Archives of internal medicine
, vol.161
, pp. 2000-2005
-
-
Monster, T.B.1
Janssen, W.M.2
de Jong, P.E.3
de Jong-van den Berg, L.T.4
-
33
-
-
13844253554
-
Contraception in diabetic women: An Italian study
-
Napoli A, Colatrella A, Botta R, Di Cianni G, Fresa R, Gamba S, et al. Contraception in diabetic women: an Italian study. Diabetes Research and Clinical Practice 2005;67:267-72.
-
(2005)
Diabetes Research and Clinical Practice
, vol.67
, pp. 267-272
-
-
Napoli, A.1
Colatrella, A.2
Botta, R.3
Di Cianni, G.4
Fresa, R.5
Gamba, S.6
-
34
-
-
0028849245
-
Subverting randomization in controlled trials
-
Schulz KF. Subverting randomization in controlled trials. JAMA 1995;274:1456-8.
-
(1995)
JAMA
, vol.274
, pp. 1456-1458
-
-
Schulz, K.F.1
-
35
-
-
0037116839
-
Allocation concealment in randomised trials: Defending against deciphering
-
Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002;359:614-8.
-
(2002)
Lancet
, vol.359
, pp. 614-618
-
-
Schulz, K.F.1
Grimes, D.A.2
-
36
-
-
0037160763
-
Blinding in randomised trials: Hiding who got what
-
Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet 2002;359:696-700.
-
(2002)
Lancet
, vol.359
, pp. 696-700
-
-
Schulz, K.F.1
Grimes, D.A.2
-
37
-
-
0037006675
-
Sample size slippages in randomised trials: Exclusions and the lost and wayward
-
Schulz KF, Grimes DA. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 2002;359:781-5.
-
(2002)
Lancet
, vol.359
, pp. 781-785
-
-
Schulz, K.F.1
Grimes, D.A.2
-
38
-
-
0025007459
-
Effects of oral contraceptives on carbohydrate and lipid metabolisms in a healthy population: The Telecom study
-
Simon D, Senan C, Garnier P, Saint-Paul M, Garet E, Thibult N, et al. Effects of oral contraceptives on carbohydrate and lipid metabolisms in a healthy population: the Telecom study. American journal of obstetrics and gynecology 1990;163:382-7.
-
(1990)
American journal of obstetrics and gynecology
, vol.163
, pp. 382-387
-
-
Simon, D.1
Senan, C.2
Garnier, P.3
Saint-Paul, M.4
Garet, E.5
Thibult, N.6
-
39
-
-
34249675464
-
-
Steel JM. Diabetes mellitus in pregnancy. In: PickupJC, WilliamsG editor(s). Textbook of diabetes;section 60. second. Oxford, UK: Blackwell Science Ltd, 1997.
-
Steel JM. Diabetes mellitus in pregnancy. In: PickupJC, WilliamsG editor(s). Textbook of diabetes;section 60. second. Oxford, UK: Blackwell Science Ltd, 1997.
-
-
-
-
40
-
-
2442649987
-
When are observational studies as credible as randomised trials?
-
Vandenbroucke JP. When are observational studies as credible as randomised trials?. The Lancet 2004;363:1728-31.
-
(2004)
The Lancet
, vol.363
, pp. 1728-1731
-
-
Vandenbroucke, J.P.1
-
41
-
-
34249685055
-
World Health Organzation
-
Reproductive Health and Research, Geneva; Switserland: World Health Organization
-
Reproductive Health and Research. World Health Organzation. Medical eligibility criteria for contraceptive use. Geneva; Switserland: World Health Organization, 2004.
-
(2004)
Medical eligibility criteria for contraceptive use
-
-
-
42
-
-
0018761887
-
Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism
-
Wynn V, Adams PW, Godsland I, Melrose J, Niththyananthan R, Oakley NW, et al. Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism. Lancet 1979;1:1045-9.
-
(1979)
Lancet
, vol.1
, pp. 1045-1049
-
-
Wynn, V.1
Adams, P.W.2
Godsland, I.3
Melrose, J.4
Niththyananthan, R.5
Oakley, N.W.6
-
43
-
-
0022457615
-
Effects of oral contraceptives on carbohydrate metabolism
-
Wynn V, Godsland I. Effects of oral contraceptives on carbohydrate metabolism. The Journal of reproductive medicine 1986;31:892-7.
-
(1986)
The Journal of reproductive medicine
, vol.31
, pp. 892-897
-
-
Wynn, V.1
Godsland, I.2
|